AirBoss of America Corp. heads into its May 6 Q1 results with a quietly improving short picture — but with the stock down nearly 9% over the past month and a cost-to-borrow tick higher this week, the setup is more ambiguous than it first appears.
The dominant trend in positioning over the past month has been short covering, not accumulation. SI as a percentage of the free float fell to 2.0% — down almost 20% over 30 days and 13% on the week alone. The bulk of that unwind happened sharply around April 20, when short shares dropped from roughly 683,000 to 542,000 in a single session. That is a meaningful retreat. Yet borrow costs have moved in the opposite direction: the cost to borrow climbed 40% on the week to 3.15% annualised, its highest point in recent weeks. A spike in borrow cost alongside falling short interest can sometimes reflect the remaining shorts paying up to hold positions — not new aggressive piling in. Availability has loosened considerably in parallel, with the lending market moving from a very tight 30–45% availability range in late March and early April to roughly 70% now, meaning there is meaningfully more room in the pool for new borrows if sentiment turns.
The ORTEX short score of 60.9 sits in moderate territory but has been drifting lower all month, consistent with the unwinding trend. It peaked around 65 in mid-April and has eased steadily since, suggesting the more intense short pressure that built up through late March and early April is dissipating rather than intensifying. The factor ranks reinforce this: days-to-cover ranks in just the 9th percentile of the universe, and the short score ranks in only the 3rd percentile — both pointing to a stock where short positioning, while not trivial, is far from extreme.
Analyst data is thin and the available mean price target of CAD 5.49 sits materially below the current price of CAD 6.95 — a gap that likely reflects stale or limited coverage rather than an active bearish call, and should not be read as a direct downside projection. The dividend history is also dated, with the last declared dividend going back to mid-2022. On valuation, the stock trades at a price-to-book of roughly 0.71 and an EV/EBITDA around 6x — modest multiples for an industrial chemicals name, though the earnings base has been volatile.
Insider activity is worth a note. Chief Strategy Officer Matthew Boccia sold a combined ~26,500 shares across several tranches in late March, realising prices between CAD 5.06 and CAD 7.16. Against that, CEO and Chairman Peter Schoch bought 25,000 shares in early December at around CAD 4.15–4.18 — a meaningful on-market purchase from the company's largest shareholder, who holds close to 18% of shares outstanding. The two moves point in different directions, with the CEO's buy predating the recent rally and the CSO's sales looking more like a trim near the top of a bounce.
Earnings history for this name shows a wide range of outcomes. The two most recent prints — both in early March — produced large one-day moves of +10.8% and +8.5% respectively, with gains extending into the following week. The earlier two events were near-flat on day one. With the Q1 report confirmed for May 6 and the AGM following on May 7, the next week will test whether the short-covering of recent weeks reflects genuine improving confidence in the business or simply positioning ahead of a catalyst. What to watch: whether the cost-to-borrow continues to climb into the print, and whether the availability tightens again — two signals that would indicate the remaining short base is digging in rather than continuing to fold.
See the live data behind this article on ORTEX.
Open BOS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
